GlassScriptPhysician profile
Michelene Todd
NPI 1962400416
$1,198.83
in general payments reported to CMS, 2019-2025
11 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $197 · 2021: $45.10 · 2022: $95.33 · 2023: $213 · 2024: $210 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $377.28 | 2019-2025 | Precision 1, Precision7, Total30 |
| Sun Pharmaceutical Industries INC. | $172.35 | 2022-2025 | Cequa |
| Allergan, INC. | $159.19 | 2020-2021 | |
| Shire North American Group INC | $99.82 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $87.50 | 2025 | Xdemvy |
| Coopervision INC. | $82.85 | 2019-2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $75.58 | 2023-2025 | Xiidra, Biotrue One Day, Infuse |
| Oyster Point Pharma, INC. | $66.24 | 2022 | |
| Novartis Pharmaceuticals Corporation | $39.61 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.14 | 2020-2021 | |
| Sight Sciences, INC. | $14.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelene Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.